Tech Company Financing Transactions
Octarine Bio Funding Round
Octarine Bio, based in Capital Region, received $2 million in funding from DSM Venturing and Oskare Capital.
Transaction Overview
Company Name
Announced On
9/21/2022
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
DSM Venturing (Lead Investor)
Oskare Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to continue the push to develop their proprietary cannabinoid platform as well as build out their technological platform for other applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Ole Maaløes Vej 3, København N
Capital Region, 2200
DK
Capital Region, 2200
DK
Phone
Undisclosed
Website
Email Address
Overview
Octarine is unlocking the power of biology to deliver innovative cannabinoid and psychedelic therapeutics
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nethaji Gallage
Chief Financial Officer
Jan Villadsen
Chief Scientific Officer
Nicholas Milne
Browse more venture capital transactions:
Prev: 9/21/2022: Future venture capital transaction
Next: 9/21/2022: Hedera Dx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs